- Recommendation ID
- NG208/16
- Question
Pharmacological management for adults with heart valve disease: What is the clinical and cost effectiveness of ACE inhibitors, angiotensin II receptor antagonists, beta‑blockers and diuretics for adults with primary severe mitral regurgitation?
- Any explanatory notes
(if applicable)
Source guidance details
- Comes from guidance
- Heart valve disease presenting in adults: investigation and management
- Number
- NG208
- Date issued
- November 2021
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 30/11/2021 |